Phase I trial of maintenance selinexor after allogeneic hematopoietic stem cell transplantation for patients with acute myeloid leukemia and myelodysplastic syndrome. uri icon

authors

  • Cooperrider, Jennifer H
  • Fulton, Noreen
  • Andrew Artz, MD, MS
  • Larson, Richard A
  • Stock, Wendy
  • Kosuri, Satyajit
  • Bishop, Michael
  • Liu, Hongtao

publication date

  • January 1, 2020